These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36865701)

  • 1. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.
    Agnihotri G; Gross AE; Seok M; Yen CY; Khan F; Ebbitt LM; Gay C; Bleasdale SC; Sikka MK; Trotter AB
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e33. PubMed ID: 36865701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Means L; Bleasdale S; Sikka M; Gross AE
    Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration.
    Britt RS; LaSalvia MT; Padival S; Patel P; McCoy C; Mahoney MV
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz496. PubMed ID: 32128338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.
    Bradley AC; Wingler MJB; Artman KL; Ward LM; Lucar J
    Ther Adv Infect Dis; 2023; 10():20499361231195966. PubMed ID: 37667754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).
    Drew R; Brenneman E; Funaro J; Lee HJ; Yarrington M; Dicks K; Gallagher D
    PLOS Digit Health; 2023 Aug; 2(8):e0000323. PubMed ID: 37531342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions.
    Madaline T; Nori P; Mowrey W; Zukowski E; Gohil S; Sarwar U; Weston G; Urrely R; Palombelli M; Pierino VF; Parsons V; Ehrlich A; Ostrowsky B; Corpuz M; Pirofski LA
    Open Forum Infect Dis; 2017; 4(2):ofx097. PubMed ID: 28852672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Huang V; Ruhe JJ; Lerner P; Fedorenko M
    BMC Pharmacol Toxicol; 2018 Aug; 19(1):50. PubMed ID: 30081959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center.
    Epperson TM; Bennett KK; Kupiec KK; Speigel K; Neely SB; Resman-Targoff BH; Kinney KK; White BP
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e15. PubMed ID: 36714295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.
    Keller SC; Ciuffetelli D; Bilker W; Norris A; Timko D; Rosen A; Myers JS; Hines J; Metlay J
    J Pharm Technol; 2013 Oct; 29(5):205-214. PubMed ID: 25621307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines.
    Ng N; Bailey P; Pryor R; Fung L; Veals C; Sabouri K; Reznicek J
    Antimicrob Steward Healthc Epidemiol; 2021; 1(1):e42. PubMed ID: 36168502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
    Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
    N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors.
    Robins A; Dishner E; McDaneld P; Rowan M; Bartek J; Jiang Y; Adachi J; Dailey Garnes NJM
    Support Care Cancer; 2022 Feb; 30(2):1643-1654. PubMed ID: 34550460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic Foot Infection and Select Comorbidities Drive Readmissions in Outpatient Parenteral Antimicrobial Therapy.
    Barnes A; Nunez M
    Am J Med Sci; 2021 Feb; 361(2):233-237. PubMed ID: 33097196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.
    Kutubi A; O'Brien L; Murphy B; Fitzpatrick P; Hurson C; Rajendran D; Feeney E; Mallon P; Waqas S
    Heliyon; 2023 Apr; 9(4):e15212. PubMed ID: 37113779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.